Open Access

Live panel discussion.

Congress Session

3 more presentations in this session

Glucagon-like peptide 1 receptor agonists & cardiovascular outcomes: What have we learned?

Speaker: Doctor M. Cavender (Chapel Hill, US)

Thumbnail

Cardiovascular effects of glucagon-like peptide 1 receptor agonists.

Speaker: Doctor M. Husain (Toronto, CA)

Thumbnail

Glucagon-like peptide 1 receptor agonist use in cardiology.

Speaker: Professor M. Petrie (Glasgow, GB)

Thumbnail

Access the full session

Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Speakers: Doctor M. Cavender, Doctor M. Husain, Professor M. Petrie
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Cardiovascular consequences post-COVID: bench to bedside – discussion.

27 August 2021

Open Access

Other post-COVID consequences: brain, kidneys and skeletal muscles.

27 August 2021

Open Access

24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

27 August 2021

This platform is supported by

logo Novo Nordisk